ARPKD/CHF Alliance Awards Grant for Fibrosis Research
The ARPKD/CHF Alliance (www.arpkdchf.org) is pleased to announce a Research Grant of $50,000 was awarded to Dr. Rebecca Wells, M.D., Assistant Professor of Medicine (Gastroenterology) and Pathology and Laboratory Medicine at the University of Pennsylvania, to study the fundamental mechanism of non-inflammatory fibrosis, unique to CHF. Such research results are critical to therapies and may have implications for other liver diseases.
The title of her project is: TGF-B Signaling and Cell-Cell Interactions in Congenital Hepatic Fibrosis. (http://www.arpkd.org/research)
Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease occur together, creating a chronic and progressive disorder that cause high infant mortality. There are no treatments or cure. Hepatic or liver fibrosis and its complications are increasingly important as individuals with ARPKD/CHF grow older and survive beyond the neonatal period.
The ARPKD/CHF Alliance received 10 Letters of Intent and 4 excellent, full research proposals upon invitation. These were reviewed by the ARPKD/CHF Alliance Research Committee utilizing NIH Gold Standard Criteria. The ARPKD/CHF Alliance is a nonprofit, public charity, and the only organization in the world solely dedicated to ARPKD/CHF.
- Contact Information
- Colleen Zak
- ARPKD.CHF Alliance
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.